UofT Libraries is getting a new library services platform in January 2021.
Learn more about the change.

Search Articles

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (6851) 6851
Book Chapter (60) 60
Magazine Article (56) 56
Newsletter (38) 38
Book / eBook (16) 16
Reference (11) 11
Newspaper Article (9) 9
Web Resource (2) 2
Conference Proceeding (1) 1
Government Document (1) 1
Report (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (5940) 5940
science & technology (5243) 5243
life sciences & biomedicine (5162) 5162
male (3824) 3824
central nervous system stimulants - adverse effects (3374) 3374
female (3156) 3156
central nervous system stimulants - therapeutic use (2372) 2372
adult (2241) 2241
psychiatry (2161) 2161
attention deficit disorder with hyperactivity - drug therapy (1895) 1895
biological and medical sciences (1795) 1795
medical sciences (1727) 1727
child (1712) 1712
adolescent (1692) 1692
neurosciences & neurology (1507) 1507
pharmacology & pharmacy (1472) 1472
central nervous system stimulants - administration & dosage (1298) 1298
neurosciences (1213) 1213
animals (1158) 1158
middle aged (1071) 1071
psychology. psychoanalysis. psychiatry (1059) 1059
pharmacology. drug treatments (1037) 1037
methylphenidate - therapeutic use (981) 981
treatment outcome (958) 958
psychopharmacology (942) 942
central nervous system stimulants - pharmacology (940) 940
attention deficit hyperactivity disorder (929) 929
pediatrics (840) 840
methylphenidate (835) 835
attention-deficit hyperactivity disorder (830) 830
methylphenidate - adverse effects (827) 827
social sciences (802) 802
neuropharmacology (796) 796
stimulants (773) 773
double-blind method (759) 759
clinical neurology (758) 758
drug therapy (752) 752
psychology (750) 750
dose-response relationship, drug (748) 748
young adult (733) 733
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer..., (676) 676
methamphetamine (656) 656
risk factors (629) 629
substance abuse (601) 601
psychopathology. psychiatry (586) 586
neurology (577) 577
methamphetamine - adverse effects (565) 565
research (562) 562
abridged index medicus (554) 554
analysis (545) 545
drug abuse (526) 526
rats (510) 510
methylphenidate - administration & dosage (501) 501
caffeine (498) 498
adhd (477) 477
health aspects (471) 471
care and treatment (460) 460
medicine & public health (440) 440
time factors (434) 434
attention deficit disorder with hyperactivity - diagnosis (423) 423
aged (421) 421
toxicology (413) 413
caffeine - adverse effects (404) 404
attention deficit disorder with hyperactivity - psychology (400) 400
children (396) 396
hyperactivity (394) 394
general & internal medicine (391) 391
child, preschool (385) 385
drug use (385) 385
psychoanaleptics: cns stimulant, antidepressant agent, nootropic agent, mood stabilizer (379) 379
comorbidity (374) 374
drugs (370) 370
medicine, general & internal (364) 364
amphetamine (348) 348
methylphenidate hydrochloride (342) 342
cross-over studies (340) 340
central nervous system stimulants (338) 338
dosage and administration (338) 338
adult and adolescent clinical studies (335) 335
nervous system (316) 316
clinical trials (310) 310
cocaine (309) 309
amphetamines (305) 305
psychology, developmental (305) 305
substance-related disorders - epidemiology (298) 298
mental disorders (296) 296
surveys and questionnaires (295) 295
usage (291) 291
brain - drug effects (288) 288
dopamine (285) 285
central nervous system (284) 284
pharmacology (277) 277
pharmacology/toxicology (276) 276
pharmacotherapy (276) 276
drug administration schedule (275) 275
attention deficit disorder with hyperactivity - epidemiology (269) 269
children & youth (269) 269
psychiatric status rating scales (264) 264
drug therapy, combination (259) 259
internal medicine (253) 253
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Collection Dvlpm't (Acquisitions) - Vendor file (3) 3
Gerstein Science - Stacks (3) 3
Online Resources - Online (3) 3
UofT at Mississauga - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
OISE - Stacks (1) 1
Robarts - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (6724) 6724
German (101) 101
French (85) 85
Spanish (34) 34
Japanese (28) 28
Danish (21) 21
Dutch (21) 21
Norwegian (20) 20
Portuguese (19) 19
Russian (19) 19
Swedish (14) 14
Italian (12) 12
Polish (11) 11
Chinese (5) 5
Czech (4) 4
Hebrew (4) 4
Finnish (3) 3
Hungarian (3) 3
Icelandic (1) 1
Romanian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


CNS drugs, ISSN 1172-7047, 2008, Volume 22, Issue 3, pp. 213 - 237
Clonidine, adverse reactions | Attention deficit hyperactivity disorder, treatment | Atomoxetine, adverse reactions | Central nervous system stimulants, adverse reactions | Bupropion, adverse reactions | Alpha 2 adrenergic receptor agonists, adverse reactions | Pharmacology & Pharmacy | Clinical Neurology | Neurosciences & Neurology | Life Sciences & Biomedicine | Psychiatry | Science & Technology | Growth Disorders - chemically induced | Mental Disorders - epidemiology | Mental Disorders - chemically induced | Cardiovascular Diseases - prevention & control | Humans | Growth Disorders - prevention & control | Mental Disorders - prevention & control | Clinical Trials as Topic | Attention Deficit Disorder with Hyperactivity - drug therapy | Antidepressive Agents - therapeutic use | Nervous System Diseases - epidemiology | Nervous System Diseases - prevention & control | Central Nervous System Stimulants - therapeutic use | Propylamines - therapeutic use | Central Nervous System Stimulants - adverse effects | Atomoxetine Hydrochloride | Growth Disorders - epidemiology | Cardiovascular Diseases - epidemiology | Nervous System Diseases - chemically induced | Cardiovascular Diseases - chemically induced | Antidepressive Agents - adverse effects | Propylamines - adverse effects | Anorexia | Hyperactivity | Complications | Attention deficit hyperactivity disorder | Clinical trials | FDA approval | Epidemiology | Cancer therapies | Carcinogenesis | Children & youth | Prescription drugs | Sleep disorders | Side effects | Stimulants | Insomnia | Cell cycle | Teenagers | Drug dosages | Seizures | Child & adolescent psychiatry | Index Medicus
Journal Article
Cochrane Database of Systematic Reviews, ISSN 1469-493X, 05/2018, Volume 2018, Issue 6, pp. CD012069 - CD012069
Journal Article